IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,258,000 | – | 215,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Svennilson Peter | 6,642,942 | $8,636,000 | 7.61% |
| Versant Venture Management, LLC | 2,208,210 | $2,870,673,000 | 1.42% |
| BVF INC/IL | 5,185,383 | $6,741,000 | 0.88% |
| EcoR1 Capital, LLC | 5,603,191 | $7,284,000 | 0.73% |
| Abingworth LLP | 352,300 | $458,000 | 0.42% |
| Bain Capital Public Equity Management, LLC | 892,061 | $1,160,000 | 0.11% |
| ALGERT GLOBAL LLC | 92,591 | $120,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 41,068 | $53,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 136,468 | $177,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,122 | $35,000 | 0.01% |